drugset / Trial / NCT01116440
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine efficacy, safety, tolerability and pharmacokinetics of multiple doses of BGS649 with concurrent daily administration of combined oral contraception in patients with refractory endometriosis
Timeline
- Start
- 2010-04-15
- Primary completion
- 2011-07
- Completion
- 2012-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BGS649 | Unknown | 0.3 mg | Oral |